moderna vaccine - Search News

Order byBest matchMost fresh

News

FDA expands approval of Moderna's RSV vaccine

· 2d · on MSN

FDA expands approval of Moderna's RSV vaccine to some adults under age 60

The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the disease.

Continue reading

Moderna Receives U.S. FDA Approval for RSV Vaccine, mRESVIA, in Adults Aged 18–59 at Increased Risk for RSV Disease

BioPharma Dive · 2d

Moderna wins FDA OK to widen use of RSV vaccine

2don MSN

Moderna falls on fears new CDC vaccine advisory panel could cloud RSV shot prospects

Moderna's shares fell 2.5% before the bell on Friday, on concerns whether a new CDC advisory panel would back the use of the ...

‘People inside Moderna are afraid’: As anti-vaccine climate intensifies, the company has much to lose

The recent downturn in biotech has battered Massachusetts’ world-renowned sector, and the political climate has only made it ...

2don MSN

HHS Misleads on mRNA Vaccine Safety After Pulling Moderna Funding

The Department of Health and Human Services has defended cuts to vaccine research with statements that mislead on the safety ...

3don MSN

Is it Time to Dump Your Shares of Moderna?

After soaring to success in the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) experienced a reversal of fortune ...

5don MSN

AstraZeneca, BioNTech, GSK, Sanofi, Moderna, Novavax, Pfizer share prices: Why are vaccine stocks down?

S hares of global vaccine makers were muted on Tuesday as investors and analysts took a "wait and watch" approach after U.S.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results